LOS GATOS, CA — (Marketwired) — 11/06/17 — Atomera Incorporated (“Atomera” or the “Company”) (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced results for the third quarter ended September 30, 2017.
Atomera announced a new customer entering trials, which increases the number of potential customers in the pivotal integration phase to five.
13 total customers are now engaged with Atomera with two new additions since last quarter.
Synopsys– latest release of its market-leading TCAD software now supports modeling Atomera–s MST technology.
Participated in marketing roadshow with Synopsys showcasing the simulation of MST.
“Our third quarter showed significant increases in customer activity, both with new trials and earlier phase engagement. Atomera–s new Synopsys TCAD capability is generating strong industry enthusiasm and helping to shorten our time to revenue,” commented Scott Bibaud, President and CEO.
During the third quarter of 2017, the Company incurred a net loss of $3.3 million, or ($0.27) per share, compared to a net loss of $3.6 million, or ($0.30) per share, in the second quarter of 2017, and a net loss of $4.1 million, or ($0.56) per share, for the third quarter of 2016. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2017 was a loss of $2.4 million compared to an adjusted EBITDA loss in the second quarter of 2017 of $2.2 million, and an adjusted EBITDA loss of $1.7 million in the third quarter of 2016.
The Company had $19.6 million in cash and cash equivalents as of September 30, 2017, compared to $21.7 million as of June 30, 2017.
The total number of shares outstanding was 12,160,637 as of September 30, 2017.
Atomera will host a conference call to discuss its financial results and recent progress. Date: Monday, November 6, 2017
Time: 1:30 p.m. PT (4:30 p.m. ET)
Phone: (844) 263-8318 (domestic)? +1 (213) 358-0960 (international)
Replay: Available until November 13, 2017 (855) 859-2056 (domestic)? +1(404) 537-3406 (international); passcode 96537935.
Webcast: Accessible at
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a nonGAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, taxes, depreciation, amortization, stockbased compensation and the change in fair value of derivative liabilities. Our definition of adjusted EBITDA may not be comparable to the definitions of similarlytitled measures used by other companies. We believe that this nonGAAP financial measure, viewed in addition to and not in lieu of its reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company–s internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
Atomera Incorporated has developed Mears Silicon Technology (“MST®”), which increases performance and power efficiency in semiconductor transistors. MST® can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nanoscaling technologies already in the semiconductor industry roadmap.
This press release contains forwardlooking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST® technology to significantly improve semiconductor performance. Those forwardlooking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that we have not yet commenced revenue producing operations or entered into a definitive agreement with regard to the licensing or commercialization of our MST technology, thus subjecting us to all of the risks inherent in a prerevenue enterprise? (2) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST® technology? (3) our ability to protect our proprietary technology, trade secrets and knowhow, and (4) those other risks disclosed in the section “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 31, 2017. We caution readers not to place undue reliance on any forwardlooking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
Frank Laurencio
(408) 442-5246
You must be logged in to post a comment Login